TY - GEN
T1 - Blue light filtering glasses and computer vision syndrome
T2 - Medical Imaging 2020: Image Perception, Observer Performance, and Technology Assessment
AU - Dabrowiecki, Alexander
AU - Villalobos, Alexander
AU - Krupinski, Elizabeth A.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Computer Vision Syndrome (CVS) is an umbrella term for a pattern of symptoms associated with prolonged digital screen exposure such as eyestrain, headaches, blurred vision, dry eyes, and neck/shoulder pain. Commercially available blue light filtering lenses (BLFL) are advertised as improving CVS. This pilot study evaluated the effectiveness of BLFL on reducing CVS symptoms and fatigue in a cohort of radiology trainees. In this Institutional Review Board approved prospective crossover study, 10 radiology residents were randomized into two cohorts: one wearing BLFL first then a sham pair (non-BLFL), and the other wearing a sham pair first then the BLFL over the course of a typical clinical work day for 5 days. Every evening, participants filled out a questionnaire based on a previously validated CVS questionnaire (CVS-Q:16 questions, Likert scale 1-5) and the Swedish Occupational Fatigue Index (SOFI: 16 questions, Likert scale 0- 10). 10 radiology residents (8 PGY-2, 1 PGY-3, and 1 PGY-4): 4 males, 6 females, participated. Although none of the 32 symptoms demonstrated statistically significant differences, 11/16 (68.8%) symptoms measured on the CVS-Q and 13/16 (81.3%) symptoms measured on the SOFI were reduced with the BLFL compared to the sham glasses. Two symptoms, "drowsy" and "lack of concern," decreased in the BLFL cohort nearing statistical significance, p = 0.057 and p = 0.075, respectively. Use of BLFL may ameliorate CVS symptoms. Future studies with larger sample sizes and participants of different ages are required to verify the potential of BLFL.
AB - Computer Vision Syndrome (CVS) is an umbrella term for a pattern of symptoms associated with prolonged digital screen exposure such as eyestrain, headaches, blurred vision, dry eyes, and neck/shoulder pain. Commercially available blue light filtering lenses (BLFL) are advertised as improving CVS. This pilot study evaluated the effectiveness of BLFL on reducing CVS symptoms and fatigue in a cohort of radiology trainees. In this Institutional Review Board approved prospective crossover study, 10 radiology residents were randomized into two cohorts: one wearing BLFL first then a sham pair (non-BLFL), and the other wearing a sham pair first then the BLFL over the course of a typical clinical work day for 5 days. Every evening, participants filled out a questionnaire based on a previously validated CVS questionnaire (CVS-Q:16 questions, Likert scale 1-5) and the Swedish Occupational Fatigue Index (SOFI: 16 questions, Likert scale 0- 10). 10 radiology residents (8 PGY-2, 1 PGY-3, and 1 PGY-4): 4 males, 6 females, participated. Although none of the 32 symptoms demonstrated statistically significant differences, 11/16 (68.8%) symptoms measured on the CVS-Q and 13/16 (81.3%) symptoms measured on the SOFI were reduced with the BLFL compared to the sham glasses. Two symptoms, "drowsy" and "lack of concern," decreased in the BLFL cohort nearing statistical significance, p = 0.057 and p = 0.075, respectively. Use of BLFL may ameliorate CVS symptoms. Future studies with larger sample sizes and participants of different ages are required to verify the potential of BLFL.
KW - Blue light filtration
KW - Image interpretation
KW - Perception
KW - Radiology residents
UR - http://www.scopus.com/inward/record.url?scp=85085246319&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085246319&partnerID=8YFLogxK
U2 - 10.1117/12.2547776
DO - 10.1117/12.2547776
M3 - Conference contribution
AN - SCOPUS:85085246319
T3 - Progress in Biomedical Optics and Imaging - Proceedings of SPIE
BT - Medical Imaging 2020
A2 - Samuelson, Frank W.
A2 - Taylor-Phillips, Sian
PB - SPIE
Y2 - 19 February 2020 through 20 February 2020
ER -